Johnson & Johnson Reports Strong Fourth-Quarter Performance Despite Stock Drop

Johnson & Johnson (NYSE:JNJ) experienced a slight drop in its stock value despite reporting a strong fourth-quarter performance. The global healthcare giant saw a 7.3% year-over-year increase in revenue, reaching $21.4 billion, surpassing estimates by $380 million. Additionally, its earnings…